These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9217923)

  • 41. Immunotoxins: a new approach to cancer therapy.
    Vitetta ES; Krolick KA; Miyama-Inaba M; Cushley W; Uhr JW
    Science; 1983 Feb; 219(4585):644-50. PubMed ID: 6218613
    [No Abstract]   [Full Text] [Related]  

  • 42. High-performance immunoaffinity chromatographic detection of immunoregulatory anti-idiotypic antibodies in cancer patients receiving immunotherapy.
    Phillips TM
    Clin Chem; 1988 Sep; 34(9):1689-92. PubMed ID: 3262021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presence and functions of immune components in the tumor microenvironment.
    Witz IP
    Adv Exp Med Biol; 2001; 495():317-24. PubMed ID: 11774586
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
    Sundstedt A; Celander M; Ohman MW; Forsberg G; Hedlund G
    Int Immunopharmacol; 2009 Aug; 9(9):1063-70. PubMed ID: 19410661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumour invasion and metastasis: therapeutic implications?
    Mareel MM; Bracke ME; Boghaert ER
    Radiother Oncol; 1986 Jun; 6(2):135-42. PubMed ID: 3526422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of in vitro tumor-infiltrating lymphocyte cytotoxicity by heteroconjugated antibodies.
    Reid I; Lundy J; Donohue JH
    J Immunol; 1992 Apr; 148(8):2630-5. PubMed ID: 1532818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preface: antibody therapies for cancer.
    Bonavida B
    Oncogene; 2007 May; 26(25):3592-3. PubMed ID: 17530012
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cytokines and receptors--their functions, structures and cloning of code genes. Lymphotoxins].
    Kasakura S
    Nihon Rinsho; 1988 May; 46(5):1036-40. PubMed ID: 3261810
    [No Abstract]   [Full Text] [Related]  

  • 49. Targeted cytokines for cancer immunotherapy.
    Lode HN; Reisfeld RA
    Immunol Res; 2000; 21(2-3):279-88. PubMed ID: 10852128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
    Herlyn D; Koprowski H
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4761-5. PubMed ID: 6289317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoclonal antibodies in cancer therapy.
    Oldham RK
    J Clin Oncol; 1983 Sep; 1(9):582-90. PubMed ID: 6366145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The biological modification of tumor cells as a means of inducing their regression: an overview.
    Kobayashi H
    J Biol Response Mod; 1986 Feb; 5(1):1-11. PubMed ID: 3514798
    [No Abstract]   [Full Text] [Related]  

  • 54. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract]   [Full Text] [Related]  

  • 55. Protein A immunoadsorption/immunoactivation: a critical review.
    Fer MF; Oldham RK
    Contemp Top Immunobiol; 1985; 15():257-76. PubMed ID: 3896643
    [No Abstract]   [Full Text] [Related]  

  • 56. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 57. Antitumor Antibodies Can Drive Therapeutic T Cell Responses.
    Wittrup KD
    Trends Cancer; 2017 Sep; 3(9):615-620. PubMed ID: 28867165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunotoxin therapy of neoplasms].
    Hashimoto N; Takatsu K
    Nihon Rinsho; 1983; 41(4):825-9. PubMed ID: 6350651
    [No Abstract]   [Full Text] [Related]  

  • 59. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
    Gorter A; Meri S
    Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reaction.
    Byfield JE; Zerubavel R; Fonkalsrud EW
    Nature; 1976 Dec 23-30; 264(5588):783-5. PubMed ID: 1012319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.